The pharma sector remains under a U.S. Section 232 investigation, with the outcome due by August.
Related Posts
A stock market hedge if this comeback is a head fake and bigger losses are ahead
Tony Zhang details a spread trade in the SPDR S&P 500 Trust.
Israeli military launches strikes on military targets in Iran, officials say
Israel launched airstrikes early Saturday targeting what it described as military targets in Iran in retaliation for a ballistic missile assault Oct. 1, officials said. […]
S&P 500 futures are little changed as index nears all-time high: Live updates
Stocks finished Tuesday’s session in the green, bringing the S&P 500 closer to its record.